KIRYAT ONO, Israel & NEW YORK--(BUSINESS WIRE)--GammaCan International, Inc. (OTC BB: GCAN), a developer of immunotherapies to treat melanoma and other cancers, today announced that Patrick Schnegelsberg, Chief Executive Officer, will provide a company overview and highlight GammaCan’s recent developments at the Israeli Equities Conference on December 13th at 12:50 PM EST in the Roosevelt Hotel in New York City.
